Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06871696

Genetic of Intellectual Deficiency and Autism Spectrum Disorders (RaDiCo-GenIDA)

The aim of this observational study is to develop an alternative database model for genetically originated intellectual disabilities. This model will take the form of an online cohort study, where the majority of clinical information will be provided by the families of the patients. Questionnaires developed by professionals but formulated in a way understandable to families will be used to gather this information.

Specifically, this study aims to collect relevant information for personalized medical management. This includes understanding the risks of specific pathological complications and potential iatrogenic effects of symptomatic treatments. The primary goal is to establish groups of individuals with intellectual disabilities and/or autism spectrum disorders (ASD) sharing the same genetic mutation. This approach will provide a better understanding of the natural history of the disease and associated comorbidities.

It is important to note that this project will only focus on patients for whom the identification of the causal mutation or penetrant copy number variation (CNV) has been determined. It excludes individuals for whom the cause of intellectual disability is unknown.

This approach will contribute to a better understanding of the genetic aspects of intellectual disabilities and ASD, while facilitating more targeted and personalized medical care for the affected patients.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

RaDiCo-GenIDA

Paris, Île-de-France Region, 75012, France

Location status: Recruiting

Location contact

Jean-Louis Mandel, Pr

PRINCIPAL_INVESTIGATOR

Sonia Gueguen, PHD

CONTACT

[email protected]

06 88 34 54 08

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be a voluntary adult (aged 18 or older)
  • Be a family member (i.e., mother/father) of patients with intellectual disabilities and/or autism spectrum disorders of known genetic origin. This includes monogenic causes as well as recurrent copy number variations (CNVs) such as deletions or duplications. Note: we also allow adult patients to participate directly if they wish and have the capacity to do so.
  • Have knowledge of the genetic cause behind intellectual disabilities or autism spectrum disorders. An exception to this rule is possible for patients with a syndrome that includes intellectual disabilities or autism spectrum disorders, and for whom genetic investigation is considered, with the approval of the project's scientific council (which will define the syndromes eligible for this exception).
  • Have the intellectual and material capabilities to complete an internet questionnaire.
  • Have read the information sheet regarding the study and agreed to the general conditions of participation in the study.

There are no restrictions based on age, gender, or potential comorbidities of the individual themselves.

Exclusion criteria

  • Patients affected by the presence of intellectual disability and/or an autism spectrum disorder of unknown genetic origin will not be able to participate in the study, except with the exception mentioned in the previous chapter.
  • It is requested that only adults enter data. However, the collected data may pertain to a minor (in the case of a parent entering data about their minor child)

Treatment and study plan

Primary outcomes

  1. Description of the clinical and "para-clinical" characteristics of the disease over time in adult and pediatric patients, depending on the type of genetic anomaly associated with the disease.

    Time frame: Day 1, Every 6 months over 5 years

Secondary outcomes

  1. Identification of new information regarding the challenges faced by individuals with Intellectual Disability/Autism Spectrum Disorder (ID/ASD), based on their age (pediatric/adult) and type of anomaly (genetic/environmental factor).

    Time frame: Day 1, Every 6 months over 5 years

  2. Search for associations between certain phenotypic and genotypic/environmental factor characteristics to which individuals have been exposed.

    Time frame: Day 1, Every 6 months over 5 years

  3. Description of the dynamics of exchanges among families (no access to content, description of the number of participating families, frequency of exchanges, etc.)

    Time frame: Day 1, Every 6 months over 5 years

Study contacts

Contact information is provided by the study sponsor or research team.

Jean-Louis Mandel, Pr

CONTACT

[email protected]

03 88 65 32 10

Sponsors and collaborators

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Other Gov

Registry information

Official study title

Genetic of Intellectual Deficiency and Autism Spectrum Disorders

Acronym: RaDiCo-GenIDA

Important dates

Study start
2016
Primary completion
2026
Study completion
2026
First posted
Mar 12, 2025
Registry last updated
Mar 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.